The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Testosterone Undecanoate-Global Market Insights and Sales Trends 2025
Synopsis
Testosterone undecanoate, sold under the brand names Nebido, Aveed, and Andriol among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is taken by mouth two to three times per day with food or given by injection into muscle once every 12 weeks or so.
The global Testosterone Undecanoate market size is expected to reach US$ 827.4 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Testosterone Undecanoate in various end use industries. The expanding demands from the Primary Hypogonadism, Hypogonadotropic Hypogonadism and Late-Onset Hypogonadism,, are propelling Testosterone Undecanoate market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Testosterone Undecanoate market, driven by demand from China, the second largest economy with some signs of stabilising, the Testosterone Undecanoate market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Testosterone Undecanoate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Testosterone Undecanoate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Testosterone Undecanoate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Testosterone Undecanoate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Testosterone Undecanoate covered in this report include Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Zhejiang Xianju Pharmaceutical and Zhejiang Medicine Co., etc.
The global Testosterone Undecanoate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine Co.
Global Testosterone Undecanoate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Testosterone Undecanoate market, Segment by Type:
Injection
Oral
Global Testosterone Undecanoate market, by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Testosterone Undecanoate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Testosterone Undecanoate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Testosterone undecanoate, sold under the brand names Nebido, Aveed, and Andriol among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is taken by mouth two to three times per day with food or given by injection into muscle once every 12 weeks or so.
The global Testosterone Undecanoate market size is expected to reach US$ 827.4 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Testosterone Undecanoate in various end use industries. The expanding demands from the Primary Hypogonadism, Hypogonadotropic Hypogonadism and Late-Onset Hypogonadism,, are propelling Testosterone Undecanoate market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Testosterone Undecanoate market, driven by demand from China, the second largest economy with some signs of stabilising, the Testosterone Undecanoate market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Testosterone Undecanoate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Testosterone Undecanoate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Testosterone Undecanoate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Testosterone Undecanoate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Testosterone Undecanoate covered in this report include Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Zhejiang Xianju Pharmaceutical and Zhejiang Medicine Co., etc.
The global Testosterone Undecanoate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine Co.
Global Testosterone Undecanoate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Testosterone Undecanoate market, Segment by Type:
Injection
Oral
Global Testosterone Undecanoate market, by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Testosterone Undecanoate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Testosterone Undecanoate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Testosterone Undecanoate Market Overview
1.1 Testosterone Undecanoate Product Overview
1.2 Testosterone Undecanoate Market Segment by Type
1.2.1 Injection
1.2.2 Oral
1.3 Global Testosterone Undecanoate Market Size by Type
1.3.1 Global Testosterone Undecanoate Market Size Overview by Type (2018-2029)
1.3.2 Global Testosterone Undecanoate Historic Market Size Review by Type (2018-2023)
1.3.3 Global Testosterone Undecanoate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Testosterone Undecanoate Sales Breakdown by Type (2018-2023)
1.4.2 Europe Testosterone Undecanoate Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Testosterone Undecanoate Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Testosterone Undecanoate Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Testosterone Undecanoate Sales Breakdown by Type (2018-2023)
2 Global Testosterone Undecanoate Market Competition by Company
2.1 Global Top Players by Testosterone Undecanoate Sales (2018-2023)
2.2 Global Top Players by Testosterone Undecanoate Revenue (2018-2023)
2.3 Global Top Players by Testosterone Undecanoate Price (2018-2023)
2.4 Global Top Manufacturers Testosterone Undecanoate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Testosterone Undecanoate Market Competitive Situation and Trends
2.5.1 Testosterone Undecanoate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Testosterone Undecanoate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Testosterone Undecanoate as of 2022)
2.7 Date of Key Manufacturers Enter into Testosterone Undecanoate Market
2.8 Key Manufacturers Testosterone Undecanoate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Testosterone Undecanoate Status and Outlook by Region
3.1 Global Testosterone Undecanoate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Testosterone Undecanoate Historic Market Size by Region
3.2.1 Global Testosterone Undecanoate Sales in Volume by Region (2018-2023)
3.2.2 Global Testosterone Undecanoate Sales in Value by Region (2018-2023)
3.2.3 Global Testosterone Undecanoate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Testosterone Undecanoate Forecasted Market Size by Region
3.3.1 Global Testosterone Undecanoate Sales in Volume by Region (2024-2029)
3.3.2 Global Testosterone Undecanoate Sales in Value by Region (2024-2029)
3.3.3 Global Testosterone Undecanoate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Testosterone Undecanoate by Application
4.1 Testosterone Undecanoate Market Segment by Application
4.1.1 Primary Hypogonadism
4.1.2 Hypogonadotropic Hypogonadism
4.1.3 Late-Onset Hypogonadism
4.2 Global Testosterone Undecanoate Market Size by Application
4.2.1 Global Testosterone Undecanoate Market Size Overview by Application (2018-2029)
4.2.2 Global Testosterone Undecanoate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Testosterone Undecanoate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Testosterone Undecanoate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Testosterone Undecanoate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Testosterone Undecanoate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Testosterone Undecanoate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Testosterone Undecanoate Sales Breakdown by Application (2018-2023)
5 North America Testosterone Undecanoate by Country
5.1 North America Testosterone Undecanoate Historic Market Size by Country
5.1.1 North America Testosterone Undecanoate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Testosterone Undecanoate Sales in Volume by Country (2018-2023)
5.1.3 North America Testosterone Undecanoate Sales in Value by Country (2018-2023)
5.2 North America Testosterone Undecanoate Forecasted Market Size by Country
5.2.1 North America Testosterone Undecanoate Sales in Volume by Country (2024-2029)
5.2.2 North America Testosterone Undecanoate Sales in Value by Country (2024-2029)
6 Europe Testosterone Undecanoate by Country
6.1 Europe Testosterone Undecanoate Historic Market Size by Country
6.1.1 Europe Testosterone Undecanoate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Testosterone Undecanoate Sales in Volume by Country (2018-2023)
6.1.3 Europe Testosterone Undecanoate Sales in Value by Country (2018-2023)
6.2 Europe Testosterone Undecanoate Forecasted Market Size by Country
6.2.1 Europe Testosterone Undecanoate Sales in Volume by Country (2024-2029)
6.2.2 Europe Testosterone Undecanoate Sales in Value by Country (2024-2029)
7 Asia-Pacific Testosterone Undecanoate by Region
7.1 Asia-Pacific Testosterone Undecanoate Historic Market Size by Region
7.1.1 Asia-Pacific Testosterone Undecanoate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Testosterone Undecanoate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Testosterone Undecanoate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Testosterone Undecanoate Forecasted Market Size by Region
7.2.1 Asia-Pacific Testosterone Undecanoate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Testosterone Undecanoate Sales in Value by Region (2024-2029)
8 Latin America Testosterone Undecanoate by Country
8.1 Latin America Testosterone Undecanoate Historic Market Size by Country
8.1.1 Latin America Testosterone Undecanoate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Testosterone Undecanoate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Testosterone Undecanoate Sales in Value by Country (2018-2023)
8.2 Latin America Testosterone Undecanoate Forecasted Market Size by Country
8.2.1 Latin America Testosterone Undecanoate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Testosterone Undecanoate Sales in Value by Country (2024-2029)
9 Middle East and Africa Testosterone Undecanoate by Country
9.1 Middle East and Africa Testosterone Undecanoate Historic Market Size by Country
9.1.1 Middle East and Africa Testosterone Undecanoate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Testosterone Undecanoate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Testosterone Undecanoate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Testosterone Undecanoate Forecasted Market Size by Country
9.2.1 Middle East and Africa Testosterone Undecanoate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Testosterone Undecanoate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bayer AG
10.1.1 Bayer AG Company Information
10.1.2 Bayer AG Introduction and Business Overview
10.1.3 Bayer AG Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer AG Testosterone Undecanoate Products Offered
10.1.5 Bayer AG Recent Development
10.2 Endo Pharmaceuticals
10.2.1 Endo Pharmaceuticals Company Information
10.2.2 Endo Pharmaceuticals Introduction and Business Overview
10.2.3 Endo Pharmaceuticals Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Endo Pharmaceuticals Testosterone Undecanoate Products Offered
10.2.5 Endo Pharmaceuticals Recent Development
10.3 Merck Sharp & Dohme
10.3.1 Merck Sharp & Dohme Company Information
10.3.2 Merck Sharp & Dohme Introduction and Business Overview
10.3.3 Merck Sharp & Dohme Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Sharp & Dohme Testosterone Undecanoate Products Offered
10.3.5 Merck Sharp & Dohme Recent Development
10.4 Taro Pharmaceutical
10.4.1 Taro Pharmaceutical Company Information
10.4.2 Taro Pharmaceutical Introduction and Business Overview
10.4.3 Taro Pharmaceutical Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Taro Pharmaceutical Testosterone Undecanoate Products Offered
10.4.5 Taro Pharmaceutical Recent Development
10.5 Cipla
10.5.1 Cipla Company Information
10.5.2 Cipla Introduction and Business Overview
10.5.3 Cipla Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Cipla Testosterone Undecanoate Products Offered
10.5.5 Cipla Recent Development
10.6 Zhejiang Xianju Pharmaceutical
10.6.1 Zhejiang Xianju Pharmaceutical Company Information
10.6.2 Zhejiang Xianju Pharmaceutical Introduction and Business Overview
10.6.3 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Products Offered
10.6.5 Zhejiang Xianju Pharmaceutical Recent Development
10.7 Zhejiang Medicine Co.
10.7.1 Zhejiang Medicine Co. Company Information
10.7.2 Zhejiang Medicine Co. Introduction and Business Overview
10.7.3 Zhejiang Medicine Co. Testosterone Undecanoate Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Zhejiang Medicine Co. Testosterone Undecanoate Products Offered
10.7.5 Zhejiang Medicine Co. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Testosterone Undecanoate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Testosterone Undecanoate Industrial Chain Analysis
11.4 Testosterone Undecanoate Market Dynamics
11.4.1 Testosterone Undecanoate Industry Trends
11.4.2 Testosterone Undecanoate Market Drivers
11.4.3 Testosterone Undecanoate Market Challenges
11.4.4 Testosterone Undecanoate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Testosterone Undecanoate Distributors
12.3 Testosterone Undecanoate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
